MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR Vβ CDR2 peptides: Comparison with myelin basic protein-specific T cells

Journal of Neuroscience Research

Volumn 45, Issue 6, 1996, Pages 838-851

  Chou, Y K ^a,b,d   Weinberg, A D ^a,c   Buenafe, A ^a,b   Bourdette, D N ^a,b   Whitham, R ^a,b   Kaleeba, J A R ^a   Robey, I F ^a   Kavanagh, D G ^a   Offner, H ^b   Vandenbark, A A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

cytokines; multiple sclerosis; myelin basic protein (MBP); second complementarity determining region (CDR2); T cell receptor V chain; Th1 cells; Th2 cells

Indexed keywords

CD30 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; CLONE CELLS; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS;

EID: 10144236520     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960915)45:6<838::AID-JNR21>3.0.CO;2-Q     Document Type: Article

References (38)

1. Bourdette DN, Whitham R, Chou YK, Morrison WJ, Atherton J, Kenny C, Liefeld D, Hashim G, Offner H, Vandenbark AA (1994): Immunity to TCR peptides in multiple sclerosis I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152:2510-2519.
2. Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER (1996): Structure and expression of murine CD30 and its role in cytokine production. J Immunol 156:442-449.
3. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989): Interaction of staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 86:8941-8945.
4. Chomczynski P, Sacchi N (1987): Single step method of RNA isolation by acid guanidinium thiocyanted-pheno-chloroform extraction. Anal Biochem 162:156-159.
5. Chou YK, Vainiene M, Whitham R, Bourdette D, Chou CHJ, Hashim G, Offner H, Vandenbark AA (1989): Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules. J Neurosci Res 23:207-216.
6. Chou YK, Henderikx P, Vainiene M, Whitham R, Bourdette D, Chou CHJ, Hashim GA, Offner H, Vandenbark AA (1991): Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein. J Neurosci Res 28:280-290.
7. Chou YK, Morrison WJ, Weinberg AD, Dedrick R, Whitham R, Bourdetted DN, Hashim G, Offner H, Vandenbark AA (1994): Immunity to TCR peptides in multiple sclerosis II. T cell recognition of Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152: 2520-2529.
8. Concannon P, Pickering LA, Kung P, Hood L (1986): Diversity and structure of human T cell receptor β-chain variable region genes. Proc Natl Acad Sci USA 83:6598-6602.
9. Del Prete G, Maggi E, Pizzolo G, Romagnani S (1995): CD30, Th2 cytokines and HIV infection: A complex and fascinating link. Immunol Today 16:76-80.
10. Diebler GE, Boyd LF, Kies MW (1984): Enzymatic and nonenzymatic degradation of myelin basic protein. Neurochemistry 9:1371-1385.
11. Ebers GC (1984): Immunogenetics and CSF studies in multiple sclerosis. In Vandenbark AA, Raus JCM (eds): "Immunoregulatory Processes in Experimental Allergic Encephalomyelitis and Multiple Sclerosis." Amsterdam: Elsevier, pp 233-256.
12. Fredrikson S, Olerup O, Olsson T, Kam-Hansen S (1988): Immunogenetic heterogeneity (HLA- DQ beta) between patients with chronic progressive and relapsing/remitting multiple sclerosis. J Neurol 235(Suppl):S42.
13. Hashim GA, Day ED, Fredane L, Intintola P, Carvalho E (1986): Biological activity of region 65 to 102 of the myelin basic protein. J Neurosci Res 16:467-478.
14. Hashim GA, Vandenbark AA, Galang AB, Diamanduros T, Carvalho E, Srinivasan J, Jones R, Vainiene M, Morrison WJ, Offner H (1990): Antibodies specific for a Vβ8 T cell receptor peptide suppress experimental autoimmune encephalomyelitis. J Immunol 144:4621-4627.
15. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989): Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668-670.
16. Jaraquemada D, Martin R, Rosen-Bronson S, Flerlage M, McFarland HF, Long EO (1990): HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol 145:2880-2885.
17. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q (1991): Messenger RNA expression of the cytokine gene cluster, Interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173:775-778.
18. Kimura N, Toyonaga B, Yoshikai Y, Du RP, Mak TW (1987): Sequences and repetoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes. Eur J Immunol 17:375-383.
19. Klohe EP, Watts R, Bahl M, Alber C, Yu WY, Anderson R, Silver J, Gregersen PK, Karr RW (1988): Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. J Immunol 141:2158-2163.
20. Kotzin BL, Karuturi S, Chou YK, Lafferty J, Forrester JM, Better M, Nedwin GE, Offner H, Vandenbark AA (1991): Preferential T cell receptor Vβ gene usage in myelin basic protein reactive T cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88:9161-9165.
21. Kurtzke JF (1965): Further notes on disability evaluation in multiple sclerosis with scale modification. Neurology 15:654-662.
22. Martin R, Howell MD, Jaraquemada D, Flerlage M, Richert J, Brostoff S, Long EO, McFarlin DE, McFarland HF (1991): A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173:19-24.
23. Mosmann TR and Sad S (1996): The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
24. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CCA, Steinman L (1993): Selection of T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68-70.
25. Offner H, Hashim G, Vandenbark AA (1991): T cell receptor peptide therapy triggers autoregulation of experimental autoimmune encephalomyelitis. Science 251:430-432.
26. Oswald IP, Caspar P, Jankovic D, Wynn TA, Pearce EJ, Sher A (1994): IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J Immunol 153:1707-1713.
27. Ottenhoff THM, Elferink DG, Klatzer PR, Vries RRP (1986): Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 322:462-464.
28. Poser CM, Paty DW, Scheinberg L, MacDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983): New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 13:227-236.
29. Racke MK, Quigley L, Cannella B, Raine CS, McFarland DE, Scott DE (1994): Superantigen modulation of experimental allergic encephalomyelitis: Activation or anergy determines outcome. J Immunol 152:2051-2059.
30. Robinson MA (1991): The human T cell receptor β-chain gene complex contains at least 57 variable gene segments: Identification of six Vβ genes in four new gene families. J Immunol 146: 4392-4397.
31. Stevens DB, Katpus WJ, Gould KE, Swanborg RH (1992): Studies of Vβ8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis. J Neuroimmunol 37:123-129.
32. Swain SL, Huston G, Tonkonogy S, Weinberg AD (1991): TGF-β and IL-4 direct helper T cell precursors to develop distinct CD4 helper cells which differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 147:2991-3000.
33. Vainiene M, Gold DP, Celnik B, Hashim GA, Vandenbark AA, Offner H (1992): Common sequence on distinct Vβ genes defines a protective idiotope in experimental encephalomyelitis. J Neurosci Res 31:413-420.
34. Vandenbark AA, Hashim G, Offner H (1989): Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544.
35. Vandenbark AA, Vainiene M, Celnik B, Hashim G, Offner H (1992): TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system. J Neuroimmunol 39:251-260.
36. Vandenbark AA, Chou YK, Whitham R, Mass M, Buenafe A, Liefeld D, Kavanagh D, Cooper S, Hashim G, Offner H, Bourdette DN (1966): Treatment of multiple sclerosis with T cell receptor peptides: Results of a double-blind pilot trial. (Submitted)
37. Voskuhl RR, Martin R, Bergman C, Dalal M, Ruddle NH, McFarland HF (1993): T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15:137-143.
38. Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, Strominger JL, Hafler DA (1994): Structural requirements for binding of an immunodominant myelin basic protein to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 179:279-290.